Authors

• Israa Salih
• Tin‐Yun Tang (ORCID: https://orcid.org/0000-0003-2030-9518)
• Mohamed H. Derbala (ORCID: https://orcid.org/0000-0002-0420-3521)
• Sarina A. Piha‐Paul (ORCID: https://orcid.org/0000-0001-9455-1660)
• Evan Kwiatkowski (ORCID: https://orcid.org/0000-0001-8398-8429)
• Marcus Anderson (ORCID: https://orcid.org/0000-0003-4848-3382)
• Hung Lê (ORCID: https://orcid.org/0000-0002-0111-6887)
• Albert R. Klekers
• Apostolia Maria Tsimberidou (ORCID: https://orcid.org/0000-0003-2713-233X)
• Jibran Ahmed (ORCID: https://orcid.org/0000-0002-3412-7689)
• Stéphane Champiat (ORCID: https://orcid.org/0000-0002-0741-2118)
• F Meric-Bernstam
• Bettzy Stephen (ORCID: https://orcid.org/0000-0003-1653-2012)
• Mingxuan Xu
• Lilibeth Castillo
• JoAnn Lim (ORCID: https://orcid.org/0000-0001-7983-3264)
• Jordi Rodon Ahnert
• Hao Yan
• Siqing Fu
• Yali Yang
• David S. Hong
• Serdar A. Gurses
• Harold N. Tan
• Ecaterina E. Dumbrava
• Lei Kang
• Priya R. Bhosale
• Timothy A. Yap
• Aung Naing

Institutions

• The University of Texas MD Anderson Cancer Center (US)
• The University of Texas Health Science Center at Houston (US)

Publication Details

Journal

Cancer Research

Published

2026-04-17

DOI

https://doi.org/10.1158/1538-7445.am2026-lb429

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00